about
Potential therapeutic targets for neurokinin-1 receptor antagonistsNSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental DataPeripheral cytokines as a chemical mediator for postconcussion like sickness behaviour in trauma and perioperative patients: literature review.Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of MigraineCocoa-enriched diets enhance expression of phosphatases and decrease expression of inflammatory molecules in trigeminal ganglion neuronsKetorolac in the treatment of acute migraine: a systematic review.Sumatriptan and naproxen sodium for the acute treatment of migraine.The discovery of a new drug class for the acute treatment of migraine.CGRP receptor antagonists: an expanding drug class for acute migraine?The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3 - inflammatory profile of pain syndromes.Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neuronsNitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons.Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.Finding new drug targets for the treatment of migraine attacks.Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigsAnti-inflammatory actions of acupuncture.Brain-derived neurotrophic factor in primary headaches.Acupoint injection of onabotulinumtoxin A for migraines.Experimental migraine models and their relevance in migraine therapy.New migraine and pain research.Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraineCGRP receptor antagonists: A new frontier of anti-migraine medications.Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice.Medullary pain facilitating neurons mediate allodynia in headache-related painBotulinum toxin type a therapy in migraine: preclinical and clinical trials.Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.Increased Serum CD14 Level Is Associated with Depletion of TNF-α in Monocytes in Migraine Patients during Interictal Period.Animal models of headache: from bedside to bench and back to bedside.Calcitonin gene-related peptide receptor antagonists for migraine.The biological basis of headache.Kynurenines and headache.The role of chemosensitive afferent nerves and TRP ion channels in the pathomechanism of headaches.Beyond Beauty: Onobotulinumtoxin A (BOTOX®) and the Management of Migraine HeadachesAnimal migraine models for drug development: status and future perspectives.Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations.Efficacy and mechanism of anticonvulsant drugs in migraine.Low 5-HT1B receptor binding in the migraine brain: A PET study.Advances in drug development for acute migraine.CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat.Two TRPV1 receptor antagonists are effective in two different experimental models of migraine.
P2860
Q28262693-1F20AE42-1AE0-4E1B-B574-5DD7C0001FEDQ31135314-44CF4B8A-8BC2-49B8-AA51-539D4F761ABDQ33607485-DABFEC1C-85AC-4C1B-905F-A02765C7A04CQ33630515-0822B90B-3D9F-48ED-8AC8-9EA6BA92B5ADQ33965206-AE8C5F2F-730A-415B-9EF4-3A38E2201E4AQ34321461-25189FFB-DFE8-4775-8F97-5CC2DC432CACQ34444092-B482AC0E-7FAE-4302-8A28-F9AD4569E65FQ34617817-37177FB5-5C32-4D64-BD13-4EFCE459E57AQ34637610-3C635DE0-C976-4BAA-A4A1-2333DFE26324Q34668480-0C1413D5-71F4-43B1-A732-779F0E78E5C3Q34708824-CEC63E76-D3F1-41E0-923A-9947DF20C118Q34708829-57723B86-8D7E-4C36-9BAD-13D4D6666263Q34720188-4593BDCE-EE52-45CB-A61D-5CAAB355C4DFQ34954050-A9CDCEFF-DC69-49A2-9ACC-DD62B8B197E3Q35045720-3605BDBA-FEC9-4C08-A91E-C688358CCAB1Q35140436-0186623D-EFAE-41D9-8DFB-D754387811E2Q36298155-44FA27F2-D4BB-46E9-BFBB-22C3D03CCA31Q36329577-81CB4873-2769-4873-9E1B-531F9A68C466Q36474260-05B1B0E6-8D21-4EAA-9C99-C52835EFC15CQ36787453-ACAB0F5F-64A8-497D-B12F-5D8DB6B5A76AQ37276146-E6640C1C-E156-4ED0-9FE8-7380631F0C6BQ37362635-EF869447-49EC-4464-8CAB-DE65BDC0C417Q37363843-0BA4D85F-FDE4-405C-93A9-6A6FBAC5543CQ37409407-E8132D81-2466-474F-8831-6BC133B93392Q37631993-1FCBBBFD-0F46-4B84-B5B8-20A9ED54DEE3Q37686124-D1D85912-76E8-457A-ACED-EEE03D6F67B1Q37690950-3E4DADB3-B76A-459B-8FB7-F335CCBF0F71Q37699421-93AD86A3-695E-456E-94C2-80DE6A8D54AEQ37756158-5978AE60-1E11-454D-9D2A-FECA215A1921Q37849764-CD8C558B-5570-466D-BE9A-189FEA67EE52Q37885234-6B261A60-0B8C-428F-9AF1-933FC64A598DQ38033056-92CF25B8-9C6E-4C24-B5D7-82A6A39778BBQ38162211-A6CB0B68-E00A-4021-84F6-A8ED91F89BD5Q38162801-6B4BA02B-B25A-42EB-97BC-EB93CEF8BC8BQ38180106-3C493E3B-A961-49CE-99BC-3AD98864E119Q38185096-A591505B-B5F7-45BD-AA00-905AD51E47ABQ38668451-3C275AE7-8ECF-412D-9537-CCAFBBA8CCDBQ39527265-3248CB42-6990-4FFA-89C4-9899CD727E2BQ41139207-64927011-687C-4EA4-B4C3-40D28A81D422Q41440081-9EFA041F-C3C5-47FC-8570-57CA255E6762
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neurogenic inflammation in the context of migraine.
@ast
Neurogenic inflammation in the context of migraine.
@en
Neurogenic inflammation in the context of migraine.
@nl
type
label
Neurogenic inflammation in the context of migraine.
@ast
Neurogenic inflammation in the context of migraine.
@en
Neurogenic inflammation in the context of migraine.
@nl
prefLabel
Neurogenic inflammation in the context of migraine.
@ast
Neurogenic inflammation in the context of migraine.
@en
Neurogenic inflammation in the context of migraine.
@nl
P2860
P356
P1476
Neurogenic inflammation in the context of migraine.
@en
P2093
D J Williamson
R J Hargreaves
P2860
P304
P356
10.1002/JEMT.1081
P577
2001-05-01T00:00:00Z